3Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction[J]. Circulation, 2012,126(16): 2020- 2035.
4Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction [J]. Eur Heart J, 2007 , 28 ( 20 ): 2525- 2538.
5Thygesen K, Mair J, Katus H, et al. Study group on biomarkers in cardiology of the ESC working group on acute cardiac care. Recommendations for the use of cardiac troponin measurement in acute cardiac carej J]. Eur Heart J, 2010,31(18): 2197-2204.
6Korley FK, Jaffe AS. Preparing the United States for highsensitivity cardiac troponin assays [J]. J Amer Coli Cardio, 2013, 61(17): 1753-1758.
7Karmen A, Wroblewski F, Ladue JS. Transaminase activity in human bloodf J}. J Clin Invest, 1955,34(1): 126-131.
9International Society and Federation of Cardiology, World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease [J]. Circulation, 1979, 59 (3 ) : 607 -609.
10Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiologyl American College of Cardiology Committee for the redefinition of myocardial infarction [J]. J Am Coli Cardiol, 2000 ,36 (3 ) : 959 -969.
